Pacific Metals
5541
Smile Holdings
7084
Reyuu Japan
9425
Architects Studio Japan
6085
Generation Pass
3195
JP Stock MarketDetailed Quotes
4553 TOWA Pharmaceutical
- 2790
- -50-1.76%
20min DelayMarket Closed Feb 28 15:30 JST
143.73BMarket Cap8.49P/E (Static)
2862High2777Low150.30KVolume2848Open2840Pre Close421.13MTurnover339552wk High0.65%Turnover Ratio51.52MShares248852wk Low391.66EPS TTM64.41BFloat Cap3560Historical High8.49P/E (Static)23.09MShs Float623Historical Low328.59EPS LYR2.99%Amplitude60.00Dividend TTM0.81P/B100Lot Size2.15%Div YieldTTM
TOWA Pharmaceutical News
TOWA Pharmaceutical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)
TOWA Pharmaceutical: Notice regarding revisions to dividend forecasts for the fiscal year ending March 31, 2025 (69th term)
TOWA Pharmaceutical: Supplementary explanation of financial results for the 3rd quarter of the fiscal year ending March 31, 2025
TOWA Pharmaceutical: Confirmation letter
TOWA Pharmaceutical: Half-Year Report - 69th Term (2024/04/01 - 2025/03/31)
TOWA Pharmaceutical: Supplementary explanation of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3
TOWA Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)
TOWA Pharmaceutical: Notice regarding revisions to earnings forecasts
TOWA Pharmaceutical: Announcement of revised financial estimates.
TOWA Pharmaceutical: Supplementary explanation materials for Q1 financial results in March 2025.
TOWA Pharmaceutical: Short-term financial statements for the first quarter of March 2025 [Japanese standards] (consolidated)
TOWA Pharmaceutical: Confirmatory letter.
TOWA Pharmaceutical: Corrected Financial Report - 68th Term (2023/04/01 - 2024/03/31)
TOWA Pharmaceutical: Extraordinary Report
TOWA Pharmaceutical: Securities Report - 68th Period (April 1, 2023 - March 31, 2024)
TOWA Pharmaceutical: Confirmation letter
TOWA Pharmaceutical: Announcements of individual stocks regarding the financial results of the parent company.
TOWA Pharmaceutical: Supplementary explanation of financial results for the fiscal year ending 2024/3
TOWA Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Towa Pharmaceutical: Confirmation